<code id='F0F979E2D2'></code><style id='F0F979E2D2'></style>
    • <acronym id='F0F979E2D2'></acronym>
      <center id='F0F979E2D2'><center id='F0F979E2D2'><tfoot id='F0F979E2D2'></tfoot></center><abbr id='F0F979E2D2'><dir id='F0F979E2D2'><tfoot id='F0F979E2D2'></tfoot><noframes id='F0F979E2D2'>

    • <optgroup id='F0F979E2D2'><strike id='F0F979E2D2'><sup id='F0F979E2D2'></sup></strike><code id='F0F979E2D2'></code></optgroup>
        1. <b id='F0F979E2D2'><label id='F0F979E2D2'><select id='F0F979E2D2'><dt id='F0F979E2D2'><span id='F0F979E2D2'></span></dt></select></label></b><u id='F0F979E2D2'></u>
          <i id='F0F979E2D2'><strike id='F0F979E2D2'><tt id='F0F979E2D2'><pre id='F0F979E2D2'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:535
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Intellia reports positive results for its CRISPR
          Intellia reports positive results for its CRISPR

          RubyWallauforSTATIntelliaTherapeuticssaidSundaythatthefirst10patientstoreceiveaCRISPR-basedtreatment

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          White House Covid adviser calls on docs to combat misinformation

          AshishJha,coordinatoroftheWhiteHouseCovidresponseteamBRENDANSMIALOWSKI/AFPviaGettyImagesWALTHAM,Mass